CAS 2260767-49-3

Rosopatamab

CAS: 2260767-49-3

Rosopatamab

Reinheit: ≥95%

Ref: 54-BUP20304

Rosopatamab

CAS: 2260767-49-3

Rosopatamab is a humanized anti-PSMA monoclonal antibody that enables targeted therapy for prostate cancer through radionuclide coupling.

Reinheit: 95%

Farbe und Form: Liquid

Molekulargewicht: 144.36kDa

Ref: TM-T78286

Rosopatamab

CAS: 2260767-49-3

Anti-Human PSMA Monoclonal Antibody

Ref: 3D-CLA1674